Corporation
Moderna Biopharma Canada Corporation
- Meetings this Parliament
- 8
- With MPs
- 3
- Since Nov 2021
- 72
- Active registrations
- 1
Most recent reported meeting: Feb 11, 2026.
Lobbying by Moderna Biopharma Canada Corporation: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
In-house (corporation) In effect since Sep 10, 2026 Receives government funding
Filed by Stefan Raos, General Manager, Canada
Lobbyists
- James Mansi · VP and Head, Medical Strategy, Resilience Markets & CMD Canada
- Laura Fitzgerald · Associate Director, External Affairs
- Leslie Madden · Federal Affairs & Policy Lead
- Lisa Wise-Milestone · Associate Director, Strategy & Operational Excellence
- Nagmeh Nikpoor · Director, Resilience R&D Partnerships, Canada
- Patricia Gauthier · General Manager, Resilience Program and Markets
- Roger Ngassam · Site Head, Canada
- Stefan Raos · General Manager
- Truong Ta · Director, Market Access & Pricing
Institutions they may lobby: Federal Economic Development Agency for Southern Ontario (FedDev), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Prairies Economic Development Canada (PrairiesCan), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC), Treasury Board Of Canada Secretariat (TBS)
What they're lobbying on (3)Hide details
- The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada
- Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models
- Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
Registration 956349-370107-21. Look it up in the official Registry
Reported meetings
SpreadsheetFiled by Patricia Gauthier (42), Stefan Raos (30).
-
Reported by Stefan Raos · In-house (corporation)
- David McFarlane · Director of Policy, Innovation, Science and Economic Development Canada (ISED)
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
-
Reported by Stefan Raos · In-house (corporation)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada Read more
Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
-
Reported by Stefan Raos · In-house (corporation)
- Mélanie Joly · Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, Innovation, Science and Economic Development Canada (ISED)
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada Read more
Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
-
Reported by Stefan Raos · In-house (corporation)
- Marjorie Michel · Minister of Health, Public Health Agency of Canada (PHAC)
- Mélanie Joly · Minister of Innovation, Sciences and Economic Development, Innovation, Science and Economic Development Canada (ISED)
- Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Nancy Hamzawi · President, Public Health Agency of Canada (PHAC)
and 3 moreShow fewer
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Andrea Gilpin · Chief of Staff, Public Health Agency of Canada (PHAC)
- Natasha Crowcroft · Vice President, Public Health Agency of Canada (PHAC)
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada Read more
Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models
Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
-
Reported by Stefan Raos · In-house (corporation)
- Andrea Gilpin · Chief of Staff, Public Health Agency of Canada (PHAC)
- Andrea Andrachuk · Director General, Public Services and Procurement Canada (PSPC)
- Heather Deehan · Director, Public Health Agency of Canada (PHAC)
Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models Read more
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada
-
Reported by Stefan Raos · In-house (corporation)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
-
Reported by Stefan Raos · In-house (corporation)
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
- David McFarlane · Director Of Policy, Innovation, Science and Economic Development Canada (ISED)
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada Read more
Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
-
Reported by Stefan Raos · In-house (corporation)
- Pierre Paul-Hus · Member of Parlliament
Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology Read more
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada
-
Reported by Stefan Raos · In-house (corporation)
- Andrea Gilpin · Chief of Staff, Public Health Agency of Canada (PHAC)
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada
-
Reported by Stefan Raos · In-house (corporation)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada Read more
Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
-
Reported by Stefan Raos · In-house (corporation)
- Gérard Deltell · Member of Parliament
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada Read more
Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
-
Reported by Stefan Raos · In-house (corporation)
- Pierre Paul-Hus · Member of Parlliament
Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology Read more
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada
-
Reported by Stefan Raos · In-house (corporation)
- Kelly Block · Member Of Parliament
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada Read more
Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
-
Reported by Stefan Raos · In-house (corporation)
- Greg Orencsak · Deputy Minister, Health Canada (HC)
Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models Read more
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada
-
Reported by Stefan Raos · In-house (corporation)
- Matt Jeneroux · Member of Parliament
Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models Read more
-
Reported by Stefan Raos · In-house (corporation)
- Arianne Reza · Associate Deputy Minister, Public Services and Procurement Canada (PSPC)
Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models Read more
-
Reported by Stefan Raos · In-house (corporation)
- Mollie Royds · Associate Assistant Deputy Minister, Public Services and Procurement Canada (PSPC)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Michelle Boudreau · Associate Assistant Deputy Minister, Health Canada (HC)
Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models Read more
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada
Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
-
Reported by Stefan Raos · In-house (corporation)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentResearch and DevelopmentScience and Technology
-
Reported by Stefan Raos · In-house (corporation)
- Michele Evans · Assistant Deputy Minister, Alberta, Prairies Economic Development Canada (PrairiesCan)
Economic DevelopmentHealth
-
Reported by Stefan Raos · In-house (corporation)
- Mollie Royds · Associate Assistant Deputy Minister, Public Services and Procurement Canada (PSPC)
Government ProcurementHealth
-
Reported by Stefan Raos · In-house (corporation)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Christopher Johnstone · Assistant Deputy Minister, Health Canada (HC)
Economic DevelopmentHealthResearch and DevelopmentScience and Technology
-
Reported by Stefan Raos · In-house (corporation)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentResearch and DevelopmentScience and Technology
-
Reported by Stefan Raos · In-house (corporation)
- Michele Evans · Assistant Deputy Minister, Alberta, Prairies Economic Development Canada (PrairiesCan)
Economic DevelopmentScience and Technology
-
Reported by Stefan Raos · In-house (corporation)
- Mark Holland · Minister of Health, Health Canada (HC)
Health
-
Reported by Stefan Raos · In-house (corporation)
- Joel Dennis · Director General, Public Health Agency of Canada (PHAC)
HealthResearch and Development
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.